LATEST NEWS AND FACTS ABOUT MEDICINES YOU TAKE

Most people may not know that Strattera appears to cause unsatisfactory sexual function (decreased libido, ejaculatory problems and impotence).

Because Strattera is a new drug (released in 2002), the long-term effects are unknown.

ABOVE: Eli Lilly and Company, "Strattera Medication Guide," rev. 5/08.

Strattera is arguably safer than methylphenidate and certainly less addicting than amphetamines (Adderall and Vyvanse). Whether Strattera is as effective for ADHD as methylphenidate (Ritalin) is questionable, but many physicians feel it is worthwhile to try it first.

ABOVE: The Essential Guide to Psychiatric Drugs—Rev. and updated (2007).

Strattera Side Effects and Warnings

  • Generic name: ATOMOXETINE HYDROCHLORIDE (atomoxetine HCl)
  • Brand name: STRATTERA

Strattera (atomoxetine) is Used for

Officially used for attention-deficit/hyperactivity disorder (ADHD), Strattera is also used as an augmenting agent to boost the effectiveness of standard antidepressants.

Do Not Use Strattera If

  • you have or had suicide thoughts or actions
  • you have heart problems, heart defects, irregular heart beat, high blood pressure, or low blood pressure
  • you have mental problems, psychosis, mania, bipolar illness, or depression
  • you have liver problems
  • you are pregnant, planning to become pregnant, or breastfeeding
  • you have an eye problem called narrow angle glaucoma
  • do not combine with a monoamine oxidase inhibitor

Manufacturer's Safety Notice

  • Strattera can exacerbate mood swings; important to note if you have Bipolar disorder

Strattera may cause serious mental health problems including suicidal thoughts and psychosis (seeing or hearing things that are not real) in children and teenagers.

ABOVE: Eli Lilly and Company, "Strattera Medication Guide," rev. 5/08.

Common Reactions to Strattera in children and teenagers

  • Mood swings
  • Tiredness
  • Dizziness
  • Nausea or vomiting
  • Decreased appetite
  • Upset stomach

Common side effects to Strattera in adults

Serious Reactions to Strattera

  • Suicidal thoughts and actions in children and teenagers. Watch for the following signs in your child or teenager during STRATTERA treatment:
    • anxiety
    • agitation
    • panic attacks
    • trouble sleeping
    • irritability
    • hostility
    • aggressiveness
    • impulsivity
    • restlessness
    • mania
    • depression
    • suicide thoughts
  • NEW Mental (psychiatric) problems in children and teenagers:
    • New psychotic symptoms (such as hearing voices, believing things that are not true, being suspicious) or new manic symptoms
  • Severe liver damage
  • Heart-related problems:
    • sudden death in patients who have heart problems or heart defects
    • stroke and heart attack in adults
    • increased blood pressure and heart rate
  • Serious allergic reactions (call your doctor if you see swelling, hives, or experience other allergic reactions)
  • Slowing of growth (height and weight) in children
  • Problems passing urine including:
    • Trouble starting or keeping a urine stream
    • Cannot fully empty the bladder

FDA "Black Box" Warning

The Food and Drug Administration (FDA) requires the following "black box" warning on Strattera (atomoxetine hydrochloride) which means that medical studies indicate these drugs carry a significant risk of serious, or even life-threatening, adverse effects.

WARNING:
SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS

STRATTERA (atomoxetine) increased the risk of suicidal ideation in short-term studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD). Anyone considering the use of STRATTERA in a child or adolescent must balance this risk with the clinical need. Co-morbidities occurring with ADHD may be associated with an increase in the risk of suicidal ideation and/or behavior. Patients who are started on therapy should be monitored closely for suicidality (suicidal thinking and behavior), clinical worsening, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. STRATTERA is approved for ADHD in pediatric and adult patients. STRATTERA is not approved for major depressive disorder.

Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials of STRATTERA in children and adolescents (a total of 12 trials involving over 2200 patients, including 11 trials in ADHD and 1 trial in enuresis) have revealed a greater risk of suicidal ideation early during treatment in those receiving STRATTERA compared to placebo. The average risk of suicidal ideation in patients receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated patients (851 patients). No suicides occurred in these trials [see Warnings and Precautions (5.1)].

ABOVE: Eli Lilly and Company, Strattera Medication Guide, rev. 5/08.

Dosage Forms of Strattera (atomoxetine HCl)

EACH STRATTERA CAPSULE CONTAINS ATOMOXETINE BASE OF:
10 mg 18 mg 25 mg 40 mg 60 mg 80 mg 100 mg
Opaque White, Opaque White Gold, Opaque White Opaque Blue, Opaque White Opaque Blue, Opaque Blue Opaque Blue, Gold Opaque Brown, Opaque White Opaque Brown, Opaque Brown
ABOVE: Eli Lilly and Company, Strattera Dosing Information: www.strattera.com/~.

Male and Female Sexual Dysfunction with Strattera
(unsatisfactory sexual experience)

Strattera appears to impair sexual function in some patients. Changes in sexual desire, sexual performance, and sexual satisfaction are not well assessed in most clinical trials because they need special attention and because patients and physicians may be reluctant to discuss them. Accordingly, estimates of the incidence of unsatisfactory sexual experience and performance cited in product labeling are likely to underestimate the actual incidence. The table below displays the incidence of sexual side effects reported by at least 2% of adult patients taking Strattera in placebo-controlled trials.

Sexual Dysfunction: STRATTERA PLACEBO
Erectile disturbance (males only) 7% 1%
Impotence (males only) 3% 0%
Orgasm abnormal (both males and females) 2% 1%

There are no adequate and well-controlled studies examining sexual dysfunction with Strattera treatment. While it is difficult to know the precise risk of sexual dysfunction associated with the use of Strattera, physicians should routinely inquire about such possible side effects.

FDA Warning: Links Between ADHD Drugs and Priapism and Sexual Dysfunction

In a recent drug-safety announcement, the FDA announced that drugs containing methylphenidate must including warnings about the risk of priapism. (Methylphenidate drugs include: Concerta, Daytrana, Focalin, Metadate, Methylin, Quillivant, and Ritalin.) It's a serious problem: priapism is a persistent, usually painful, erection that lasts for more than four hours and occurs without sexual stimulation. If the condition is not treated immediately, it can lead to scarring and permanent erectile dysfunction.

The FDA included an even stronger warning about atomoxetine (Strattera): “Priapism appears to be more common in patients taking atomoxetine than in patients taking methylphenidate products. Health care professionals should be cautious when considering changing patients from methylphenidate to atomoxetine.”

The safety warning also raised concerns about links between priapism and amphetamine drugs, which include Adderall, Dexedrine, ProCentra and Vyvanse.

ABOVE: U.S. FDA Drug Safety Communication: FDA warns of rare risk of long-lasting erections in males taking methylphenidate ADHD medications and has approved label changes. (12/17/2013).

If Strattera Does Work

In addition to known possible life-threatening side effects which include sudden death in children and adolescents, Strattera can can impair your thinking and reactions, especially highlighted if you drive or do anything that requires you to be awake and alert. Both you and those living around you should be alert for changes in mood or symptoms. Especially watch for signs of depression or thoughts of hurting yourself or thoughts of suicide.

Strattera is not designed for long-term use. ADHD, however, may be a long-term condition. Thus, the drug manufacturer says the physician's decision to use Strattera should be as a part of a total treatment program for ADHD that may include counseling or other therapies.

Abrupt cessation of Strattera or other changes in Strattera dosage (both decreases and increases) can result in suicidal thoughts or suicidal actions in children and teenagers.

ABOVE: Eli Lilly and Company, "Strattera Medication Guide," rev. 5/08.

If Strattera Doesn't Work

When used for ADHD, if Strattera doesn't work, the next stronger drug is usually used instead, generally one of the versions of methylphenidate (Ritalin).

Long-Term Use of Strattera

Since it's a new medication (released in 2002), the long-term effects of Strattera are unknown.

The effectiveness of Strattera for long-term use, i.e. for more than 9 weeks in children and teenagers and 10 weeks in adults, has not been systematically evaluated in controlled trials. Therefore, the physician who elects to use Strattera for extended periods should periodically reevaluate the long-term usefulness of the drug for the individual patient.

A Completely Safe, Non-Drug Natural Approach

Powerfully effective, but totally safe, research shows Flavay® and Flavay Plus® can help all ages with improved mental focus, concentration and attention.

Placebo-controlled and double-blind trials prove that young university students experience significantly less stress from tests, stay more clear-headed and composed, and keep a more stable mood when taking Flavay PlusŪ.

[Click here for a Safe, Effective, Non-Drug Alternative]

FDA Issues Suicide Warning on Strattera

as reported by Associated Press (September 29, 2005)

The FDA directed Eli Lilly and Company, the manufacturer of Strattera (atomoxetine), to revise the prescribing information to include a boxed warning and additional warning statements that alert health care providers of an increased risk of suicidal thinking in children and adolescents being treated with this medication.

The FDA also informed Lilly that a Patient Medication Guide (MedGuide) should be provided to patients when Strattera is dispensed. The MedGuide advises patients of the risks associated with and precautions that can be taken when Strattera is dispensed. Further, pediatric patients being treated with Strattera should be closely observed for clinical worsening, as well as agitation, irritability, suicidal thinking or behaviors, and unusual changes in behavior, especially during the initial few months of a course of Strattera therapy, or at times of dose changes, either increases or decreases.

If you have taken a newly released medication, you, too, are part of the great ongoing clinical trial. When a new drug is approved less than half of its serious reactions are known. The FDA relies upon you, the consumer, to determine the other half.

ABOVE: Cohen, J.S. Over Dose: The Case Against the Drug Companies: Prescription Drugs, Side Effects, and Your Health. New York: Penguin Putnam Inc., 2001.

New Medications: Are You a Drug Guinea Pig?

Drug companies have realized the enormous demand for psychiatric medications and are actively working on many new ones. When a manufacturer brings out a new drug, they advertise it aggressively. However, pre-marketing trials, performed to satisfy the FDA requirements for new drugs, test at most a few thousand people in a very structured environment.

The FDA considers the first years in the marketplace as Phase IV of a clinical trial because that's when the drug is really put to the test, treating a diverse cross-section of the population.

  • SOURCES:
  • Eli Lilly and Company, "Strattera Medication Guide," rev. 6/09: www.fda.gov/downloads/Drugs/DrugSafety/ucm089138.pdf.
  • Eli Lilly and Company, "Medication Guide," rev. 7/08: pi.lilly.com/us/strattera-ppi.pdf
  • Eli Lilly and Company, "Important Safety Information," rev. 2010: www.strattera.com/~.
  • Physicians' Desk Reference, 58th ed. Montvale, NJ: Thomson PDR, 2004.
  • Gorman, Jack M. The Essential Guide to Psychiatric Drugs—Rev. and updated, 4th ed. New York, NY: St. Martin's Press, 2007.
  • Cohen, J.S. Over Dose: The Case Against the Drug Companies: Prescription Drugs, Side Effects, and Your Health. New York: Penguin Putnam Inc., 2001.
  • Drummond, E.H. The Complete Guide to Psychiatric Drugs: Straight Talk for Best Results, Rev. and expanded. New Jersey: John Wiley & Sons Inc., 2006.
Are you, your child, or a friend suffering from Attention Deficit Disorder? Click here for a Safe, Effective, Non-Drug Alternative

All pediatric patients being treated with Strattera should be monitored closely for suicidal thoughts or suicidal actions, clinical worsening, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes.

ABOVE: Eli Lilly and Company, "Medication Guide" pi.lilly.com/us/strattera-ppi.pdf.

What is the most important information I should know about STRATTERA?

The following have been reported with use of STRATTERA:

1. Suicidal thoughts and actions in children and teenagers:

Children and teenagers sometimes think about suicide, and many report trying to kill themselves. Results from STRATTERA clinical studies with over 2200 child or teenage ADHD patients suggest that some children and teenagers may have a higher chance of having suicidal thoughts or actions. Although no suicides occurred in these studies, 4 out of every 1000 patients developed suicidal thoughts. Tell your child or teenager's doctor if your child or teenager (or there is a family history of):

  • has bipolar illness (manic-depressive illness)
  • had suicide thoughts or actions before starting STRATTERA

The chance for suicidal thoughts and actions may be higher:

  • early during STRATTERA treatment
  • during dose adjustments

Prevent suicidal thoughts and action in your child or teenager by:

  • paying close attention to your child or teenager's moods, behaviors, thoughts, and feelings during STRATTERA treatment
  • keeping all follow-up visits with your child or teenager's doctor as scheduled

Watch for the following signs in your child or teenager during STRATTERA treatment:

  • anxiety
  • agitation
  • panic attacks
  • trouble sleeping
  • irritability
  • hostility
  • aggressiveness
  • impulsivity
  • restlessness
  • mania
  • depression
  • suicide thoughts

Call your child's or teenager's doctor right away if they have any of the above signs, especially if they are new, sudden, or severe. Your child or teenager may need to be closely watched for suicidal thoughts and actions or need a change in medicine.

2. Severe liver damage:

STRATTERA can cause liver injury in some patients. Call your doctor right away if you or your child has the following signs of liver problems:

  • itching
  • right upper belly pain
  • dark urine
  • yellow skin or eyes
  • unexplained flu-like symptoms

3. Heart-related problems:

  • sudden death in patients who have heart problems or heart defects
  • stroke and heart attack in adults
  • increased blood pressure and heart rate

Tell your doctor if you or your child has any heart problems, heart defects, high blood pressure, or a family history of these problems. Your doctor should check you or your child carefully for heart problems before starting STRATTERA.

Your doctor should check your blood pressure or your child's blood pressure and heart rate regularly during treatment with STRATTERA.

Call your doctor right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting while taking STRATTERA.

4. NEW mental (psychiatric) problems in children and teenagers:

  • new psychotic symptoms (such as hearing voices, believing things that are not true, being suspicious) or new manic symptoms

Call your child or teenager's doctor right away about any new mental symptoms because adjusting or stopping STRATTERA treatment may need to be considered.

ABOVE: Eli Lilly and Company, "Strattera Medication Guide," rev. 5/08: www.fda.gov/~

How Safe is Ritalin?

Many think methylphenidate (Ritalin) is safe, or mild, because so many children use it. However, the government classifies the psychoactive drug with cocaine and morphine because it is highly addictive. [More]

Focalin Side Effects and Warnings

Focalin is a chemical variant of methylphenidate, dextro- or dexmethylphenidate, and also comes in an XR version. Naturally, the manufacturer claims it is better than other versions of methylphenidate, but that claim is met with skepticism by many psychopharmacologists. [More]

Vyvanse is a “Pro-Drug”

Although Vyvanse is referred to as “pro-drug” of dextroamphetamine, it is still an amphetamine, meaning that it is easily abused and can cause insomnia, agitation, anxiety and sometimes psychotic symptoms like seeing things or becoming paranoid. The difference between Vyvanse and Adderall is that Vyvanse will work only if it is swallowed so that drug abusers will not be able to snort it or inject it. It is hoped this will limit abuse of Vyvanse. [More]

Adderall XR Side Effects

In small doses amphetamines can banish tiredness and make the user feel alert and refreshed. However, the burst of energy comes at a price. A "speed crash" always follows the high and may leave the person feeling nauseous, irritable, depressed and extremely exhausted. [More]

What is Your Adderall IQ?

Amphetamine Advantage or Dangerous Delusion?

Like athletes who use steroids, students who use Adderall to enhance academic performance are in many ways victims. [More]

Are you, your child, or a friend suffering from Attention Deficit Disorder? Click here for a Safe, Effective, Non-Drug Alternative

A Completely Safe, Non-Drug Natural Approach to Normalizing Healthy Brain Function

Flavay® and Flavay Plus® can help people of all ages with improved mental focus, concentration and attention.

Placebo-controlled studies and double-blind trials proved that young, university students experienced significantly less stress from tests, stayed more clear-headed and composed, and kept a more stable mood when taking the active ingredient in Flavay Plus®.

Researchers found that Flavay® worked as well as the commonly prescribed stimulant medications, including Ritalin, on thirty children and adults diagnosed with attention disorders. The difference is that Flavay® and Flavay Plus® nourish the brain. Read what customers are saying:.

“I just watched a mother come in to my school, where I'm the school nurse, to give her child Flavay® and Flavay Plus® because she had forgotten to give them to the child before leaving for school. The mother told me that they had tried Strattera and Concerta and all sorts of other things and were never happy with them, adding: ‘This Flavay® is the best there is, it's terrific.’ So, I looked it up on the Internet and I'm going to try some for my daughter's ADD and acne.”
—Ms. Kim K.

“I want to thank your company for Flavay Plus®. My aunt and grandmother had Alzheimer's. In my early 50's I was beginning to experience some memory problems, but not anymore, and I'm grateful.”
—Ms. Lynne M.

“Flavay® is terrific. I've had concentration problems, well, for 60 years, all my life. I couldn't have direct eye contact with people when talking with them because I couldn't concentrate. I told jokes but couldn't make people laugh because I couldn't keep my concentration. Now I can look people in the eye. Now I can make people laugh! I don't know how it works but it works and it is terrific.”
—Mr. Wayne S.

“Depression and anxiety sort of run in my family but I always said I didn't have that affliction. Eventually my grandmother told me she could tell from some of the things I said that I did have some degree of depression. I wasn't convinced. Then I started taking Flavay® and Flavay Plus® and I felt a new positive psychological outlook. Sometimes I would take 2 capsules of each and sometimes 4 capsules of each since I had read online that some people like taking 4 of each better. When I ran out of Flavay® and Flavay Plus® I didn't reorder because I was feeling so good.

“After a week or two I started returning to my old outlook of 'I don't care, I'll do my own thing,' and at this point I could compare and see that I must have some depression issues after all. So I do want to keep taking Flavay® and Flavay Plus® because they do help.”
—Ms. Amy C.

LEGAL DISCLAIMER: This website is for general information purposes only. Statements and excerpts from research literature are provided solely as a forum for commentary and specifically not as health or medical advice. Only your physician should diagnose your health problem and prescribe treatment. DO NOT CHANGE OR STOP TAKING MEDICATION BASED ON INFORMATION YOU READ AT THIS WEBSITE. If you have a question about a drug, or if you think you are experiencing a drug's side effect, consult with your doctor.
  • Copyright © 1995-2014 Research Publishing Co., LLC. All rights reserved. Use of this website constitutes acceptance of the Terms of Use.